Agios Pharmaceuticals, Inc. (AGIO)
33.61
+0.66
(+2.00%)
USD |
NASDAQ |
Sep 17, 16:00
33.65
+0.04
(+0.12%)
After-Hours: 07:37
Agios Pharmaceuticals 30-Day Average Daily Volume : 926773.8 for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 926773.8 |
| September 16, 2026 | 925405.8 |
| September 15, 2026 | 932369.4 |
| September 14, 2026 | 926885.0 |
| September 11, 2026 | 970470.6 |
| September 10, 2026 | 1.050M |
| September 09, 2026 | 1.064M |
| September 08, 2026 | 1.058M |
| September 04, 2026 | 1.064M |
| September 03, 2026 | 1.078M |
| September 02, 2026 | 1.086M |
| September 01, 2026 | 1.091M |
| August 31, 2026 | 1.173M |
| August 28, 2026 | 1.158M |
| August 27, 2026 | 1.166M |
| August 26, 2026 | 1.157M |
| August 25, 2026 | 1.151M |
| August 24, 2026 | 1.148M |
| August 21, 2026 | 1.151M |
| August 20, 2026 | 1.169M |
| August 19, 2026 | 1.164M |
| August 18, 2026 | 1.161M |
| August 17, 2026 | 1.214M |
| August 14, 2026 | 1.198M |
| August 13, 2026 | 1.187M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.193M |
| August 11, 2026 | 1.185M |
| August 10, 2026 | 1.180M |
| August 07, 2026 | 1.272M |
| August 06, 2026 | 1.251M |
| August 05, 2026 | 1.246M |
| August 04, 2026 | 1.240M |
| August 03, 2026 | 1.250M |
| July 31, 2026 | 1.285M |
| July 30, 2026 | 1.246M |
| July 29, 2026 | 1.168M |
| July 28, 2026 | 1.184M |
| July 27, 2026 | 1.194M |
| July 24, 2026 | 1.234M |
| July 23, 2026 | 1.239M |
| July 22, 2026 | 1.256M |
| July 21, 2026 | 1.243M |
| July 20, 2026 | 1.148M |
| July 17, 2026 | 1.149M |
| July 16, 2026 | 1.146M |
| July 15, 2026 | 1.158M |
| July 14, 2026 | 1.166M |
| July 13, 2026 | 1.191M |
| July 10, 2026 | 1.200M |
| July 09, 2026 | 1.194M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.496M |
| Biogen, Inc. | 739073.4 |
| Insmed, Inc. | 2.394M |
| Alnylam Pharmaceuticals, Inc. | 1.644M |
| Regeneron Pharmaceuticals, Inc. | 656937.0 |